Skip to main content
  1. Market Insights
  2. Health
  3. Cannabis

Medical Cannabis - LATAM

LATAM
  • The revenue in the Medical Cannabis market market in LATAM is forecasted to reach US$1.15bn in 2024.
  • It is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 2.96%, leading to a market volume of US$1.33bn by 2029.
  • When compared globally, the United States is set to generate the highest revenue, amounting to US$14.53bn in 2024.
  • In terms of per person revenues, US$4.09k are generated in 2024 relative to the total population figures.
  • The Medical Cannabis market in LATAM is experiencing rapid growth, with Colombia emerging as a key player in cultivation and export.

Definition:
The Medical Cannabis market encompasses products derived from the cannabis plant specifically used for medical purposes. These products may include dried flowers, oils, tinctures, capsules, and topicals. Depending on the regulations in each country or state, these products are available through medical dispensaries, pharmacies, and/or online platforms. They may be consumed in various ways such as smoking, vaporizing, ingesting, or applying topically.

Structure:
The Medical Cannabis market involves cannabinoid-based medicine without marketing authorisation. These unlicensed medicines are supplied through health systems, prescribed by doctors, or used as Active Pharmaceutical Ingredients (API). The API is manipulated and/or compounded by a magistral pharmacy to prepare a cannabinoid-based medicine without marketing authorisation. The Medical Cannabis market includes various forms of cannabis such as flowers, oils, capsules, and topicals.

Additional information:
Market values represent the revenues generated by retail prices paid to vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by patients (B2C), healthcare facilities (B2B), and governments (B2G).

In-Scope

  • Cannabinoid-based medicine not holding marketing authorisation containing THC
  • Cannabinoid-based medicine not holding marketing authorisation containing CBD

Out-Of-Scope

  • Cannabinoid-based medicine holding marketing authorisation containing THC
  • Cannabinoid-based medicine holding marketing authorisation containing CBD
Medical Cannabis: market data & analysis - Cover

Market Insights report

Medical Cannabis: market data & analysis

Study Details

    Revenue

    Notes: Data was converted from local currencies using average exchange rates of the respective year.

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Users

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Analyst Opinion

    The Medical Cannabis market in LATAM is experiencing significant growth and development driven by changing customer preferences, evolving trends, local special circumstances, and underlying macroeconomic factors.

    Customer preferences:
    Customers in LATAM are increasingly turning to medical cannabis products due to growing awareness of its potential health benefits and therapeutic properties. The shift towards natural and alternative medicine options is driving demand for medical cannabis as consumers seek non-traditional treatments for various health conditions.

    Trends in the market:
    In countries like Colombia and Uruguay, where medical cannabis regulations are more progressive, there is a noticeable trend towards increased cultivation and production of medical cannabis. These countries are positioning themselves as key players in the global medical cannabis market by leveraging their favorable climate conditions and cost-effective production capabilities.

    Local special circumstances:
    LATAM countries have unique regulatory environments that impact the medical cannabis market. While some countries have fully legalized medical cannabis and established robust regulatory frameworks, others are still in the process of developing their legislation. These varying degrees of legalization and regulation create opportunities and challenges for market players operating in the region.

    Underlying macroeconomic factors:
    The economic landscape in LATAM plays a significant role in the development of the medical cannabis market. Countries facing economic challenges may view medical cannabis as a potential source of revenue through taxation and job creation. Additionally, foreign investment in the medical cannabis industry is influenced by macroeconomic factors such as exchange rates, inflation rates, and political stability in the region.

    Global Comparison

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

    Modeling approach / Market size:

    Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

    Additional Notes:

    The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

    Health

    Access more Market Insights on Health topics with our featured report

    Medical Cannabis: market data & analysis - BackgroundMedical Cannabis: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Cannabis market worldwide - Statistics & Facts

    Cannabis or marijuana, the psychoactive drug from the cannabis plant is growing in popularity around the globe, both for recreational and medicinal uses. While there are many countries that have legalized cannabis in some capacity for medical purposes, only a handful have done so for recreational use. Even though cannabis is not federally legal in the United States, the combined legal states represent the largest market in the world. After the U.S., Canada, which legalized cannabis nation-wide in 2018 represents the next largest market. In 2021, a new coalition government was formed in Germany that indicated that the legalization of cannabis was on their agenda. Germany would be the largest legal adult-use market in Europe and would act as a test case for other countries on the continent considering the merits of legalization.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.